|
An attorney representing a consumer provided a summary statement associated with a medical event.On (b)(6) 2016, the consumer was reported to have purchased the product.That night, the consumer was reported to remove his lenses and put them into a contact case containing the product.The consumer left his contacts to soak in the solution, and then he was reported to have put them back in on (b)(6) 2016.Upon putting the contacts in, the customer was reported to have felt an instant burning sensation that he attributed to the new solution.The consumer indicated the burning subsided about 20 minutes later.Throughout the day, the consumer was reported to recall his vision being "cloudy" or "smoky".The consumer called and made an appointment with an optometrist for a routine eye appointment as he was due anyway.The appointment was set for (b)(6) 2016.The consumer was reported to have proceeded through the day with the irritation to his eyes somewhat subsiding but still present.The next morning, (b)(6) 2016, the eyes were reported to still bother the consumer, so he took out his contacts.Upon doing so, the burning sensation was reported to return with greater intensity.At the scheduled eye examination, the optometrist examined the eye and the consumer was reported to have been given wetting drops and an antibiotic drop.No additional medical information/records from the examination was provided.Consumer departed from optometrist¿s office but was reported to still have pain and therefore went to an emergency room.It was reported that the hospital staff flushed the consumer¿s eyes and provided vicodin.Hospital staff also recommended that the consumer make an appointment with another doctor for the following day.On (b)(6) 2016, a doctor examined the consumer¿s eyes and was reported to comment that 80% of the left eye cornea and 60% of the right eye cornea had burned.It was also reported that muscles in the eyes were contracting due to the trauma.The doctor was reported to have indicated stem cell treatment was the recommended therapy.In addition to the vicodin, the consumer was reported to have been prescribed an antibiotic eye drop, a muscle relaxer eye drop, a gel antibiotic ointment, lubricating eye drops, and a steroid antibiotic eye drop.It was reported that the consumer underwent three stem cell treatments.No additional medical information/records from the examination was provided.
|
|
The complaint sample was returned for evaluation and the results of the chemical testing performed were consistent with shelf life limits.Additionally, a review of the lot batch records and testing of a retain sample concluded that the product was formulated, manufactured, and packaged according to local and global product specifications.Based on available information, no causal factors can be determined and no conclusion can be drawn.
|